Bionyra Pharma
Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases.
$165MSeries A
Role not disclosedSP
Sofinnova Partners
Activity from announced rounds
Activity in this selectionEnterprise software
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $192.9M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionIngenix
Builds AI architecture fusing biological data modalities to accelerate pharma and biotech drug development
€13MSeed+
Role not disclosedBrightHeart
BrightHeart develops AI software for prenatal ultrasound and fetal-heart screening.
€11MSeries A
Role not disclosed